Effect of erythropoietin on oxygen-induced brain injury in the newborn rat
Related Experiment Video
Updated: Jun 28, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Uluç Yiş1, Semra Hiz Kurul, Abdullah Kumral
1Department of Pediatric Neurology, School of Medicine, Dokuz Eylül University, Inciralti, 35340 Izmir, Turkey. ulyis@yahoo.com
Insights
Erythropoietin (EPO) protects developing rat brains from hyperoxia-induced injury. This study shows EPO significantly reduces neuronal apoptosis in the hippocampus and cortex, suggesting potential therapeutic benefits.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- The developing nervous system is vulnerable to high oxygen levels (hyperoxia).
- Hyperoxia exposure in infant rats causes significant brain damage, including apoptosis.
- Erythropoietin (EPO) has demonstrated neuroprotective effects in various models.
Purpose of the Study:
- To investigate the neuroprotective potential of erythropoietin (EPO) against hyperoxia-induced brain injury in developing Wistar rats.
- To evaluate the effect of EPO on neuronal cell death and apoptosis in the developing brain under hyperoxic conditions.
Main Methods:
- Eighteen Wistar rat pups were divided into control, hyperoxia+saline, and hyperoxia+erythropoietin groups.
- Hyperoxia groups were exposed to 80% oxygen for 5 days (24h/day).
- Erythropoietin (1000 U/kg/day) was administered intraperitoneally to the treatment group; apoptosis was assessed at postnatal day 5.
Main Results:
- Histopathological examination revealed significantly reduced apoptosis in the hippocampus (CA1 region and dentate gyrus) and parietal cortex of the hyperoxia+erythropoietin group.
- Erythropoietin treatment effectively diminished hyperoxia-induced neuronal cell death.
Conclusions:
- Erythropoietin demonstrates significant neuroprotective effects against hyperoxia-induced brain damage in developing rats.
- EPO may be a beneficial therapeutic agent for preventing or mitigating hyperoxic brain injury in vulnerable infants.
Abstract:
The developing nervous system is sensitive to supraphysiological oxygen concentrations. Recent studies showed that exposure to hyperoxia in infant rats leads to extensive apoptotic degeneration in the cortex and white matter of the developing brain. A wide variety of experimental studies have shown that erythropoietin exerts a remarkable neuroprotection in both cell cultures and in animal models of nervous system disorders. In the present study, we investigated the effect of erythropoietin against hyperoxia-induced neurodegeneration in the developing brain. Eighteen Wistar rat pups were divided into three groups: control group, hyperoxia+saline-treated group and hyperoxia+erythropoietin-treated group. Hyperoxia groups were exposed to 80% oxygen (n=12) in a plexiglas chamber in which the oxygen concentration was monitored twice daily from birth until postnatal day 5. Hyperoxia exposure was 24h/day for 5 days. The hyperoxia+erythropoietin group received an intraperitoneal injection of recombinant human erythropoietin at a dose of 1000U/(kgday). At postnatal day 5, all animals were sacrificed. Neuronal cell death and apoptosis were evaluated. Histopathological examination showed that erythropoietin significantly diminished apoptosis in the CA1 region and dentate gyrus of hippocampus and parietal cortex in hyperoxia+erythropoietin-treated group. Regarding the safety profile of erythropoietin in premature and mature infants, this agent may be potentially beneficial in preventing hyperoxic brain injury.
